Kris A. Reedquist
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Mucosal kinase activity and inflammatory profiles in inflammatory bowel disease, and in relation to tofacitinib response.
Journal: Journal of Crohn's & colitis
Published: September 23, 2025
HOXA5 is a key regulator of class 3 semaphorins expression in the synovium of rheumatoid arthritis patients.
Journal: Rheumatology (Oxford, England)
Published: May 30, 2022
Cytokine receptor clustering in sensory neurons with an engineered cytokine fusion protein triggers unique pain resolution pathways.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 10, 2021
Hypoxia and TLR9 activation drive CXCL4 production in systemic sclerosis plasmacytoid dendritic cells via mtROS and HIF-2α.
Journal: Rheumatology (Oxford, England)
Published: January 04, 2021
Central Role of Semaphorin 3B in a Serum-Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 19, 2020
cDC1 are required for the initiation of collagen-induced arthritis.
Journal: Journal of translational autoimmunity
Published: July 09, 2020
Extracellular SPARC cooperates with TGF-β signalling to induce pro-fibrotic activation of systemic sclerosis patient dermal fibroblasts.
Journal: Rheumatology (Oxford, England)
Published: June 28, 2019
Promotion of macrophage activation by Tie2 in the context of the inflamed synovia of rheumatoid arthritis and psoriatic arthritis patients.
Journal: Rheumatology (Oxford, England)
Published: December 26, 2018
Induction of Inflammation and Fibrosis by Semaphorin 4A in Systemic Sclerosis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 16, 2018
New insights into the genetics and epigenetics of systemic sclerosis.
Journal: Nature reviews. Rheumatology
Published: October 12, 2018
Histone modifications underlie monocyte dysregulation in patients with systemic sclerosis, underlining the treatment potential of epigenetic targeting.
Journal: Annals of the rheumatic diseases
Published: August 16, 2018
Editorial: Lessons Learned From a "Failed" Clinical Trial.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: April 02, 2018
Last Updated: 09/26/2026